For information on a site near you, call our call center at 1-877-CTLILLY (1-877-285-4559)

Philadelphia, Pennsylvania

0 studies enrolling now · 2 studies all time

What they study most

Colorectal Cancer, Diabetes Mellitus, Non-Insulin-Dependent

Studies at this site

• A Phase 2 Trial of ALIMTA (LY231514, Pemetrexed) Plus Oxaliplatin Administered Every 21 Days for First-Line Treatment of Patients With Advanced Colorectal Cancer. — Completed
• An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 Diabetes — Completed